Natiijooyinka Raadinta
Soo bandhiga 521 - 530 ee natiijooyinka 3688
Bixiye
QP79-24 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective January 1, 2025
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2024
Bixiye
QP81-24 Health Equity Certification 2025 Launch
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2024
Bixiye
QP78-24 MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective December 1, 2024
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2024
Bixiye
QP84-24 Commercial Pharmacy Benefit Exclusion for Tremfya® and Ocrevus Zunovo™
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2024
Bixiye
P75-24 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans Managed by Blue Cross and Blue Shield of Alabama
Taariikhda uu dhaqangalayo Barnaamijka: Des 02, 2024
Bixiye
Vasomotor Symptoms (formerly Neurokinin Receptor Antagonists) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Des 01, 2024
Bixiye
QP83-24 MHCP Pharmacy Benefit Exclusion for Tremfya®, Tecentriq Hybreza™ and Ocrevus Zunovo™
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2024
Bixiye
QP82-24 Enhanced Authorization Submissions through Availity Essentials
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2024